Tirzepatide as Monotherapy: The SURPASS-1 Trial | RemedyX Labs Research Library

A research summary of Efficacy and Safety of a Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide (SURPASS-1), examining tirzepatide as monotherapy: the surpass-1 trial. Cited source and RUO context from RemedyX Labs.